Loading

PeerCurrent.com|Stay current with the people and research shaping what comes next.

PcPeerCurrent

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Set your cadence Alerts Settings Help

Back to follows

Drug or technology

CYB004

1 development in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials1 Reviews Guidelines

Latest

Everything in the corpus, newest first.

AUG 13, 2026 · PHASE 2 TRIAL

A Study of a N, N-dimethyltryptamine (DMT) Analog (CYB004) in Participants With Generalized Anxiety Disorder (GAD)

ClinicalTrials.gov

This is a Phase 2 proof-of-concept trial with completed enrollment but no results posted in this registry record; early-phase design and stated purpose to examine safety and preliminary efficacy support preliminary classification.

PreliminaryNCT06051721 Cybin IRL CYB004

Reported

Planned enrollment36

PhasePhase 2

Primary outcome measureHamilton Anxiety Rating Scale (HAM-A)

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support